Skip to main content
OpenTrials

Clinical trial condition

Anaplastic Thyroid Cancer

Explore clinical trials studying Anaplastic Thyroid Cancer. Study availability and eligibility vary by location and protocol.

21 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Anaplastic Thyroid Cancer trial results

Completed

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

NCT02404441

Conditions
Anaplastic Thyroid Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health and Science University SC-10 Portland, Oregon, United States
  • Sarah Cannon Research Institute SCRI RC Nashville, Tennessee, United States
View all 41 locations
View Trial Details
Completed

Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer

NCT02726503

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • IUHW Ichikawa Hospital Ichikawa, Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
View all 23 locations
View Trial Details
Active, Not Recruiting

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

NCT03085056

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

NCT04238624

Conditions
Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

NCT05696548

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Hokkaido University Hospital Hokkaido, Japan
  • Hyogo Cancer Center Akashi, Hyōgo, Japan
View Trial Details

Related conditions